Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
328.3 GBX | -0.97% | -1.00% | +1.97% |
May. 21 | Bernstein becomes more optimistic for consumer goods - Henkel upgraded | DP |
May. 17 | UK's FTSE 100 Closes Lower Amid Inflation Focus | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an enterprise value anticipated at 3.33 times the sales for the current fiscal year, the company turns out to be overvalued.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.97% | 38.49B | B | ||
+37.78% | 723B | C+ | ||
+31.10% | 598B | B | ||
-3.51% | 364B | C+ | ||
+19.94% | 331B | B- | ||
+5.14% | 288B | C+ | ||
+16.30% | 244B | B+ | ||
-4.79% | 208B | A+ | ||
+10.02% | 210B | B- | ||
+9.32% | 169B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HLN Stock
- Ratings Haleon plc